[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SNDX FY25-FY34 analyst consensus revenue estimates v. $RYTM $OCUL & $LQDA. Raw data bottom right SNDX forecast to outsell OCUL & LQDA but trades @ XX% the MC WTF SNDX is forecast to generate same revenues as RYTM next X years yet trades @ 1/5th the MC $XBI $INCY $IBB $NBI"
X Link @NightOwlBiotech 2025-09-16T14:02Z 1382 followers, 4193 engagements
"Valuation related data points of the X most mature commercial-stage bios (non-BP). None are forecast to double sales in the next XX years. Are there other analytics we should consider or peers that s/b added $OGN $BMRN $PTCT $ALKS $ACAD $ANIP $JAZZ $INCY $EXEL $XBI $IBB $NBI"
X Link @NightOwlBiotech 2025-09-14T13:15Z 1380 followers, 1156 engagements
"$TVTX (kidney) trades @ 0.12X 10-year revenue estimates while peer $MIRM (liver) @ 0.32X. Other comm'l-stage bios like $NBIX $ALKS $PTCT $ACAD & $AXSM trade @ 0.21-0.30X Filspari is patented thru 7/34 Is it the 1/2026 PDUFA in FSGS Any guidance w/b appreciated $XBI $NBI $LABU"
X Link @NightOwlBiotech 2025-08-07T16:43Z 1380 followers, 2846 engagements
"$NVCR reported Q225 sales this morning. NVCR trades at XXX - $3.0X FY2025 consensus which is lower than peer $EXEL at 5.0X+ & $LEGN at 7.0X+ (though NVCR gross margins are in the 70s where most peers are in the 90s). $XBI $NBI"
X Link @NightOwlBiotech 2025-07-24T13:31Z 1380 followers, 1833 engagements